comparemela.com

Jonathan Kurtis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ocean Biomedical, Inc (NASDAQ: OCEA) Announces Patent

Providence, RI, May 16, 2024 (GLOBE NEWSWIRE) Ocean Biomedical (NASDAQ:OCEA) announced today that Scientific Co-founder Dr. Jonathan Kurtis, MD, PhD,.

United statesJake kurtisJonathan kurtisChirinjeev kathuriaWarren alpert medical school at brown universityOcean biomedical incCompany annual report on formLaboratory medicineScientific co founderOcean biomedicalGlobal unmet needWarren alpert medical schoolChief executive officerRhode island basedAnnual reportQuarterly report

EXCLUSIVE: Ocean Biomedical s JV Partner Virion Therapeutics Dosed First Patients In Novel Immunotherapy Study For Chronic Hepatitis B - Ocean Biomedical (NASDAQ:OCEA)

Ocean Biomedical, Inc.

New zealandHong kongUnited statesFalk medical research trust transformational awardOcean biomedical incVirion therapeuticsSue currieChief scientistJonathan kurtis

EXCLISIVE: Ocean Biomedical s JV Partner Virion Therapeutics Dosed First Patients In Novel Immunotherapy Study For Chronic Hepatitis B - Ocean Biomedical (NASDAQ:OCEA)

Ocean Biomedical, Inc.

Hong kongNew zealandUnited statesOcean biomedical incFalk medical research trust transformational awardVirion therapeuticsSue currieChief scientistJonathan kurtis

Analysis suggests climate change, population growth could supercharge malaria risk

Longer transmission seasons and migration of mosquitoes to new latitudes threaten to undo years of progress.

United statesJonathan kurtisWashington postFalk medical research trust transformational awardSouth americaOcean biomedical

AstraZeneca submits FDA application for self-administered FluMist

The company expects an FDA decision in the first quarter of 2024.

United statesJonathan kurtisFalk medical research trust transformational awardWashington postSouth americaOcean biomedical

vimarsana © 2020. All Rights Reserved.